Explants of Inflammatory Bowel Disease tissue in culture
Case Study: Using human blood vessels to determine dose and time-dependent activity of a novel therapy for renal and vascular diseases
Fresh, Functional Human Tissues and the Prediction of Drug Safety
Improving the Prediction of Oral Bioavailability Using Fresh Human Intestinal Tissue
Obesity, Diet and Type II Diabetes Risk
Obesity and Type II Diabetes Risk; A Multinational Study
Fish and Dairy Consumption and reduced risk of breast Cancer
Exercise and Reduced Breast Cancer Risk; A Multinational Study
Physical Activity, Diet and Ovarian Cancer Risk
Family History of Cancer in First-degree Relatives and Increased Cancer Risk: A Multinational Study
Effects of Breast-feeding and Oral Contraception on the Risk of Recurrence in Breast Cancer: A Multinational Study
The Use of StemRNA iPSC Derived Human Ventricular Cardiac Tissue for Clinical Applications
Generation of Hypoimmune Hemapoetic Progenitors from HLA Class-I and Class-II null iPSC Line
Electrophysiological Nociceptive and Itch Assessment of Human iPSC-Derived Sensory Neurons Using Multi-Electrode Array (MEA) And Their Potential as an Alternative Model for Dorsal Root Ganglia
mRNA for Integration-free Cell Fate Manipulation
Introduction to mRNA Reprogramming
RNA-mediated generation of integration-free iPS cell lines from late-outgrowth endothelial progenitor cells (L-EPCs) derived from human blood
A novel transfection protocol for deriving iPS cell lines from human blood-derived endothelial progenitor cells (EPCs) and adult human dermal fibroblasts using a cocktail of non-modified reprogramming and immune evasion mRNAs
miRNA-facilitated self-replicative RNA (srRNA) reprogramming of endothelial progenitor cells (EPCs) derived from human peripheral blood and cord blood
Use of non-modified RNAs for the derivation of clinically-relevant iPS cell lines from human blood, urine and skin cells using GMP-compliant reagents
Generation of clinically compatible and genetically stable iPS cell lines from human peripheral and cord blood using microRNA-facilitated srRNA reprogramming
RNA-mediated generation of integration-free iPS cell lines from late-outgrowth endothelial progenitor cells (L-EPCs) derived from human blood
mRNA-based Methods for Cell Fate Manipulation
Cell culture under perfusion conditions reduces cellular metabolic stress and mimics the in vivo physiological environment in pancreatic cancer
A poster from the university of Oxford (UK) by Hughes D, Willenbrock F, Reddy S, Silva MA, Soonawalla Z, Mukherjee S, O'Neill E (2019).
Side by side: An evaluation of 2D vs. 3D cell culture for High Throughput Screening in Drug Discovery
Drug resistance mechanisms in FGFR-driven cancers
Explants of Inflammatory Bowel Disease tissue in culture
Target-based drug activity and post-translational and transcriptional analysis using ex vivo Alvetex Scaffold three-dimensional cell culture technology
Novel culture medium using a small-molecule agonist of thrombopoietin receptor
Human iPSC-derived hepatocytes ReproHepato™ for CYP assay and drug toxicity testing
Development of a novel xeno-free medium for feeder-free culture of human stem cells
Development of a Novel Medium for culturing Naïve iPS Cells
Human iPS cell-derived neurons and their applications for disease model research and development
Functional improvement of iPS cell-derived Hepatocyte (ReproHepato™) by utilizing 3D culture system
Improvement of Human iPS Cell-Derived Hepatocyte Functionality Using 3D Culture System
Human iPSC-derived hepatocytes and cardiomyocytes for drug toxicity testing
Human iPS cell-Derived Cardiomyocytes ReproCardio2™ as an Analytic Tool for Large-scale Toxicity Screening
Novel culture medium (ReproHSC™) for human hematopoietic stem cells with a small-molecule agonist of thrombopoietin receptor
